Annual Total Long Term Liabilities
$67.11 M
+$55.43 M+474.64%
December 1, 2024
Summary
- As of March 12, 2025, SLNO annual total long term liabilities is $67.11 million, with the most recent change of +$55.43 million (+474.64%) on December 1, 2024.
- During the last 3 years, SLNO annual total long term liabilities has risen by +$57.36 million (+588.12%).
- SLNO annual total long term liabilities is now at all-time high.
Performance
SLNO Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$67.11 M
+$50.07 M+293.73%
December 1, 2024
Summary
- As of March 12, 2025, SLNO quarterly total long term liabilities is $67.11 million, with the most recent change of +$50.07 million (+293.73%) on December 1, 2024.
- Over the past year, SLNO quarterly long term liabilities has stayed the same.
- SLNO quarterly long term liabilities is now at all-time high.
Performance
SLNO Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
SLNO Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +474.6% | 0.0% |
| 3 y3 years | +588.1% | 0.0% |
| 5 y5 years | +267.5% | 0.0% |
SLNO Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +659.5% | at high | +665.1% |
| 5 y | 5-year | at high | +659.5% | at high | +665.1% |
| alltime | all time | at high | >+9999.0% | at high | >+9999.0% |
Soleno Therapeutics Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $67.11 M(+474.6%) | $67.11 M(+293.7%) |
| Sep 2024 | - | $17.05 M(+19.8%) |
| Jun 2024 | - | $14.22 M(+18.7%) |
| Mar 2024 | - | $11.99 M(+2.6%) |
| Dec 2023 | $11.68 M(+32.2%) | $11.68 M(+3.0%) |
| Sep 2023 | - | $11.34 M(+16.6%) |
| Jun 2023 | - | $9.72 M(+6.4%) |
| Mar 2023 | - | $9.13 M(+3.4%) |
| Dec 2022 | $8.84 M(-9.4%) | $8.84 M(-6.4%) |
| Sep 2022 | - | $9.44 M(+1.4%) |
| Jun 2022 | - | $9.31 M(+6.1%) |
| Mar 2022 | - | $8.77 M(-10.1%) |
| Dec 2021 | $9.75 M(-9.8%) | $9.75 M(-26.8%) |
| Sep 2021 | - | $13.32 M(+2.6%) |
| Jun 2021 | - | $12.98 M(+34.8%) |
| Mar 2021 | - | $9.63 M(-11.0%) |
| Dec 2020 | $10.82 M(-40.8%) | $10.82 M(-31.5%) |
| Sep 2020 | - | $15.78 M(+10.2%) |
| Jun 2020 | - | $14.32 M(-6.7%) |
| Mar 2020 | - | $15.35 M(-16.0%) |
| Dec 2019 | $18.26 M | $18.26 M(+75.8%) |
| Sep 2019 | - | $10.39 M(-40.4%) |
| Jun 2019 | - | $17.44 M(+34.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | $12.99 M(+19.6%) |
| Dec 2018 | $10.86 M(+3.7%) | $10.86 M(-23.1%) |
| Sep 2018 | - | $14.12 M(-9.3%) |
| Jun 2018 | - | $15.56 M(+36.9%) |
| Mar 2018 | - | $11.37 M(+8.6%) |
| Dec 2017 | $10.47 M(+2379.8%) | $10.47 M(+626.7%) |
| Sep 2017 | - | $1.44 M(-8.3%) |
| Jun 2017 | - | $1.57 M(+1.4%) |
| Mar 2017 | - | $1.55 M(+266.8%) |
| Dec 2016 | $422.30 K(-76.3%) | $422.30 K(-48.5%) |
| Sep 2016 | - | $820.00 K(-19.9%) |
| Jun 2016 | - | $1.02 M(+4.8%) |
| Mar 2016 | - | $977.00 K(-45.3%) |
| Dec 2015 | $1.78 M(-90.2%) | $1.78 M(-30.0%) |
| Sep 2015 | - | $2.55 M(-16.4%) |
| Jun 2015 | - | $3.05 M(-85.0%) |
| Mar 2015 | - | $20.31 M(+11.0%) |
| Dec 2014 | $18.30 M(-27.6%) | $18.30 M(-56.9%) |
| Sep 2014 | - | $42.48 M(+2.9%) |
| Jun 2014 | - | $41.30 M(+65.0%) |
| Mar 2014 | - | $25.03 M(-1.0%) |
| Dec 2013 | $25.27 M(+0.4%) | $25.27 M |
| Dec 2012 | $25.17 M | - |
FAQ
- What is Soleno Therapeutics annual total long term liabilities?
- What is the all time high annual total long term liabilities for Soleno Therapeutics?
- What is Soleno Therapeutics annual total long term liabilities year-on-year change?
- What is Soleno Therapeutics quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Soleno Therapeutics?
- What is Soleno Therapeutics quarterly long term liabilities year-on-year change?
What is Soleno Therapeutics annual total long term liabilities?
The current annual total long term liabilities of SLNO is $67.11 M
What is the all time high annual total long term liabilities for Soleno Therapeutics?
Soleno Therapeutics all-time high annual total long term liabilities is $67.11 M
What is Soleno Therapeutics annual total long term liabilities year-on-year change?
Over the past year, SLNO annual total long term liabilities has changed by +$55.43 M (+474.64%)
What is Soleno Therapeutics quarterly total long term liabilities?
The current quarterly long term liabilities of SLNO is $67.11 M
What is the all time high quarterly long term liabilities for Soleno Therapeutics?
Soleno Therapeutics all-time high quarterly total long term liabilities is $67.11 M
What is Soleno Therapeutics quarterly long term liabilities year-on-year change?
Over the past year, SLNO quarterly total long term liabilities has changed by $0.00 (0.00%)